P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797254310342426624 |
|---|---|
| author | S Basu R Ghosh D Yadav M Banerjee R Shrivastava A Gautam A Middya N Mane N Rawat D Pryde A Surya S Middya S Debnath M Padaliya S Bano |
| author_facet | S Basu R Ghosh D Yadav M Banerjee R Shrivastava A Gautam A Middya N Mane N Rawat D Pryde A Surya S Middya S Debnath M Padaliya S Bano |
| author_sort | S Basu |
| collection | DOAJ |
| first_indexed | 2024-04-24T21:47:55Z |
| format | Article |
| id | doaj.art-6f4fa277235942aab5ceb34796c5d0dc |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-04-24T21:47:55Z |
| publishDate | 2024-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-6f4fa277235942aab5ceb34796c5d0dc2024-03-20T19:55:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-03-0112Suppl 110.1136/jitc-2024-ITOC10.18P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activityS Basu0R Ghosh1D Yadav2M Banerjee3R Shrivastava4A Gautam5A Middya6N Mane7N Rawat8D Pryde9A Surya10S Middya11S Debnath12M Padaliya13S Bano14Department of Pediatrics, NRS Medical College and Hospitals, Calcutta, West Bengal, India2Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USAPaediatrics, PGIMER, Dr. RML Hospital, N Delhi, India2School of Medicine, University of Liverpool, LiverpoolDepartment of Internal Medicine, Park Ridge Hospital, Rochester, New York1Curadev Pharma, Noida, India1Curadev Pharma, Noida, India1Curadev Pharma, Noida, India1Curadev Pharma, Noida, India2Curadev Pharma, Sandwich, UK1Curadev Pharma, Noida, India1Curadev Pharma Pvt Ltd, Noida, India1Curadev Pharma Pvt Ltd, Noida, India1Curadev Pharma Pvt Ltd, Noida, India1Curadev Pharma Pvt Ltd, Noida, India |
| spellingShingle | S Basu R Ghosh D Yadav M Banerjee R Shrivastava A Gautam A Middya N Mane N Rawat D Pryde A Surya S Middya S Debnath M Padaliya S Bano P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity Journal for ImmunoTherapy of Cancer |
| title | P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity |
| title_full | P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity |
| title_fullStr | P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity |
| title_full_unstemmed | P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity |
| title_short | P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity |
| title_sort | p01 08 discovery of crd1601 a potent and selective hpk1 inhibitor with robust in vivo anti cancer activity |
| work_keys_str_mv | AT sbasu p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT rghosh p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT dyadav p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT mbanerjee p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT rshrivastava p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT agautam p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT amiddya p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT nmane p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT nrawat p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT dpryde p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT asurya p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT smiddya p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT sdebnath p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT mpadaliya p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity AT sbano p0108discoveryofcrd1601apotentandselectivehpk1inhibitorwithrobustinvivoanticanceractivity |